Back to Clinical Trials Overview

Your search for "Aging" returned 19 results:

Seniors' Health Literacy, Beliefs, and Asthma Self-Management
Principal Investigator(s): Federman, Alex D.

Function and structure of human olfactory system with aging in normal subjects
Principal Investigator(s): Tang, Cheuk Ying

Inflammation, long-term diabetes characteristics, and cognitive decline
Principal Investigator(s): Schnaider-Beeri, Michal

Prolonging Remission in Depressed Elderly
Principal Investigator(s): Kellner, Charles

A Randomized, Placebo Controlled, Parallel-Group, Double Blind Efficacy and Safety Trial of MK-8931 in Subjects with Mild to Moderate Alzheimer's Disease (EPOCH)
Principal Investigator(s): Judith Neugroschl

Effects of Glycoxidative Stress on Human Aging
Principal Investigator(s): He, John Cijiang

Late Effects of Traumatic Brain Injury
Principal Investigator(s): Wayne Gordon

Improving Pain and Function in Hip Fracture
Principal Investigator(s): Morrison, Sean R

Home-based Primary Care for Homebound Seniors: A Randomized Controlled Trial (HOME Study)
Principal Investigator(s): Alex Federman

Open label long term tolerability and Efficacy of APL-1302677 (apomorphine) in Levodoa responsive patients with PD having "OFF episodes"
Principal Investigator(s): Winona Tse

Protocol H8A-MC-LZAZ(a)/ADC-040-A4 Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Principal Investigator(s): Mary Sano

Alzheimer’s Disease Neuroimaging Initiative-2 (ADNI-2)
Principal Investigator(s): Hillel Grossman

The Study of Nasal Insulin to Fight Forgetfulness
Principal Investigator(s): Hillel Grossman

A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients with Parkinson’s Disease Experiencing End of Dose "Wearing-Off"
Principal Investigator(s): Winona Tse

Clinic-based vs. home-based support to improve outcomes for older asthmatics
Principal Investigator(s): Alex Federman

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravenously Administered BMS-986168 in Participants with Progressive Supranuclear Palsy
Principal Investigator(s): Winona Tse

NOBLE: A Phase 2 multi-center randomized double-blind placebo-controlled study to evaluate the efficacy and safety of T-817 in patients with mild to moderate Alzheimer's disease
Principal Investigator(s): Amy Aloysi

Health Insurance Navigators for Low Income Elderly
Principal Investigator(s): Federman, Alex D.

The TOMMORROW Study: A Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Simultaneously Qualify a Biomarker Algorithm for Prognosis of Risk of Developing Mild Cognitive Impairment due to Alzheimer's Disease (MCI due to AD) and to Test the Safety and Efficacy of Pioglitazone (AD-4833 SR 0.8 mg QD) to Delay the Onset of MCI due to AD in Cognitively Normal Subjects
Principal Investigator(s): Judith Neugroschl